Also trades as: 0IIM.L (LSE) · $vol 0M
ESPR NASDAQ
Esperion Therapeutics, Inc.
1W: +0.3%
1M: +58.9%
3M: -10.1%
YTD: -15.6%
1Y: +244.4%
3Y: +84.1%
5Y: -86.3%
$3.13
+0.00 (+0.00%)
Weekly Expected Move ±28.1%
$1
$2
$3
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$418M
Revenue
+61.1% YoY
$-7M
Net Income
+95.2% YoY
$-18M
Free Cash Flow
+81.9% YoY
56.8%
Gross Margin
-8.2%
Op. Margin
-31.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE2.1%
ROA-1.8%
ROIC76.6%
Valuation
P/E-106.0
P/B-2.6
EV/EBITDA13.8
Leverage
Debt/Equity-1.81
Current Ratio0.56
Interest Cov.1.7x
Quality Scores
Piotroski F4/9
Altman Z-3.24
Beneish M1567.29